71 related articles for article (PubMed ID: 22850273)
1. BLyS expression and JNK activation may form a feedback loop to promote survival and proliferation of multiple myeloma cells.
Xu G; Shen XJ; Pu J; Chu SP; Wang XD; Wu XH; Sun CJ; Zhang X; Zhu BL; Ju SQ
Cytokine; 2012 Nov; 60(2):505-13. PubMed ID: 22850273
[TBL] [Abstract][Full Text] [Related]
2. B-Lymphocyte stimulator: a new biomarker for multiple myeloma.
Jiang P; Yueguo W; Huiming H; Hongxiang Y; Mei W; Ju S
Eur J Haematol; 2009 Apr; 82(4):267-76. PubMed ID: 19187273
[TBL] [Abstract][Full Text] [Related]
3. [Expression of B lymphocyte stimulator and its receptors in multiple myeloma cells: a mechanism for the cell growth and survival].
Pu J; Wang YG; Wang M; Yuan HX; Ju SQ
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):247-50. PubMed ID: 19731825
[TBL] [Abstract][Full Text] [Related]
4. Correlation of expression levels of BLyS and its receptors with multiple myeloma.
Ju S; Wang Y; Ni H; Wang X; Jiang P; Kong X; Zhong R
Clin Biochem; 2009 Mar; 42(4-5):387-99. PubMed ID: 19028483
[TBL] [Abstract][Full Text] [Related]
5. Poly(I:C) induces BLyS-expression of airway fibroblasts through phosphatidylinositol 3-kinase.
Yamada T; Lizhong S; Takahashi N; Kubo S; Narita N; Suzuki D; Takabayashi T; Kimura Y; Fujieda S
Cytokine; 2010 May; 50(2):163-9. PubMed ID: 20089415
[TBL] [Abstract][Full Text] [Related]
6. Binding of B-cell maturation antigen to B-cell activating factor induces survival of multiple myeloma cells by activating Akt and JNK signaling pathways.
Shen X; Guo Y; Qi J; Shi W; Wu X; Ju S
Cell Biochem Funct; 2016 Mar; 34(2):104-10. PubMed ID: 26914861
[TBL] [Abstract][Full Text] [Related]
7. Interference with nuclear factor kappa B and c-Jun NH2-terminal kinase signaling by TRAF6C small interfering RNA inhibits myeloma cell proliferation and enhances apoptosis.
Chen H; Li M; Campbell RA; Burkhardt K; Zhu D; Li SG; Lee HJ; Wang C; Zeng Z; Gordon MS; Bonavida B; Berenson JR
Oncogene; 2006 Oct; 25(49):6520-7. PubMed ID: 16702955
[TBL] [Abstract][Full Text] [Related]
8. [Effect of miR-202 on the growth of multiple myeloma cells via regulating B cell-activating factor and the underlying mechanism].
Yu JJ; Shen XJ; Wang XD; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):886-91. PubMed ID: 24506956
[TBL] [Abstract][Full Text] [Related]
9. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
10. Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies.
Shivakumar L; Ansell S
Clin Lymphoma Myeloma; 2006 Sep; 7(2):106-8. PubMed ID: 17026820
[TBL] [Abstract][Full Text] [Related]
11. Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.
Adler V; Qu Y; Smith SJ; Izotova L; Pestka S; Kung HF; Lin M; Friedman FK; Chie L; Chung D; Boutjdir M; Pincus MR
Biochemistry; 2005 Aug; 44(32):10784-95. PubMed ID: 16086581
[TBL] [Abstract][Full Text] [Related]
12. Growth-arrest-dependent expression and phosphorylation of p27kip at serine10 is mediated by the JNK pathway in C6 glioma cells.
Mielke K
Mol Cell Neurosci; 2008 Jul; 38(3):301-11. PubMed ID: 18513991
[TBL] [Abstract][Full Text] [Related]
13. JNK MAPK signaling contributes in vivo to injury-induced corneal epithelial migration.
Okada Y; Saika S; Shirai K; Yamanaka O; Kitano A; Wang Z; Yang H; Reinach P
Ophthalmic Res; 2009; 42(4):185-92. PubMed ID: 19672126
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
Hideshima T; Chauhan D; Hayashi T; Podar K; Akiyama M; Mitsiades C; MItsiades N; Gong B; Bonham L; de Vries P; Munshi N; Richardson PG; Singer JW; Anderson KC
Cancer Res; 2003 Dec; 63(23):8428-36. PubMed ID: 14679006
[TBL] [Abstract][Full Text] [Related]
15. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
[TBL] [Abstract][Full Text] [Related]
16. Mitogen-activated protein kinase expression and activation does not differentiate benign from malignant mesothelial cells.
Vintman L; Nielsen S; Berner A; Reich R; Davidson B
Cancer; 2005 Jun; 103(11):2427-33. PubMed ID: 15830375
[TBL] [Abstract][Full Text] [Related]
17. Sodium 4-phenylbutyrate induces apoptosis of human lung carcinoma cells through activating JNK pathway.
Zhang X; Wei L; Yang Y; Yu Q
J Cell Biochem; 2004 Nov; 93(4):819-29. PubMed ID: 15389886
[TBL] [Abstract][Full Text] [Related]
18. Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway.
Li W; Chen Z; Gong FR; Zong Y; Chen K; Li DM; Yin H; Duan WM; Miao Y; Tao M; Han X; Xu ZK
Eur J Cancer; 2011 Nov; 47(17):2654-64. PubMed ID: 21958460
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
[TBL] [Abstract][Full Text] [Related]
20. BLyS and B cell homeostasis.
Woodland RT; Schmidt MR; Thompson CB
Semin Immunol; 2006 Oct; 18(5):318-26. PubMed ID: 16931037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]